In another study, overexpression of CCNB1 in HNSCC tumors has been shown as a marker of resistance to radiotherapy and the risk of locoregional recurrence and metastasis in patients treated with radiotherapy [49]. This evidence concerns the gene CCNB1 and head and neck squamous cell carcinoma.